539 related articles for article (PubMed ID: 14578586)
1. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
Matsuyama S; Matsumoto A
J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
[TBL] [Abstract][Full Text] [Related]
2. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus.
Matsuyama S; Matsumoto A; Enomoto T; Nishizaki T
Eur J Neurosci; 2000 Oct; 12(10):3741-7. PubMed ID: 11029644
[TBL] [Abstract][Full Text] [Related]
3. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
4. Volatile anesthetic isoflurane inhibits LTP induction of hippocampal CA1 neurons through α4β2 nAChR subtype-mediated mechanisms.
Piao MH; Liu Y; Wang YS; Qiu JP; Feng CS
Ann Fr Anesth Reanim; 2013 Oct; 32(10):e135-41. PubMed ID: 24011619
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.
Welsby P; Rowan M; Anwyl R
Eur J Neurosci; 2006 Dec; 24(11):3109-18. PubMed ID: 17156372
[TBL] [Abstract][Full Text] [Related]
6. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
8. Amyloid β-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons.
He YX; Wu MN; Zhang H; Qi JS
Synapse; 2013 Jan; 67(1):11-20. PubMed ID: 23015319
[TBL] [Abstract][Full Text] [Related]
9. Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice.
Nakauchi S; Sumikawa K
Eur J Neurosci; 2012 May; 35(9):1381-95. PubMed ID: 22462479
[TBL] [Abstract][Full Text] [Related]
10. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
11. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
[TBL] [Abstract][Full Text] [Related]
12. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
Talka R; Salminen O; Tuominen RK
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
[TBL] [Abstract][Full Text] [Related]
13. The alpha4beta2 nicotinic acetylcholine receptor agonist TC-2559 impairs long-term potentiation in the dentate gyrus in vivo.
Wang Y; Sherwood JL; Lodge D
Neurosci Lett; 2006 Oct; 406(3):183-8. PubMed ID: 16935422
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
16. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region.
Fujii S; Jia Y; Yang A; Sumikawa K
Brain Res; 2000 Apr; 863(1-2):259-65. PubMed ID: 10773216
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
18. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
[TBL] [Abstract][Full Text] [Related]
19. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus.
Welsby PJ; Rowan MJ; Anwyl R
Eur J Neurosci; 2009 Jan; 29(1):65-75. PubMed ID: 19077124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
